GLPwatch
Trials (2036)
Page 30 of 34.
- Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study
- A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
- A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
- A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults
- IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
- Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
- Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
- A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
- Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
- Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
- A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
- 2024 Tirzepatide-Bariatric Surgery
- Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
- A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
- A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
- Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study
- A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
- Tirzepatide Weight Loss for MRD+ Early Breast Cancer
- Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder
- A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
- A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
- A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
- A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
- The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
- Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
- A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
- Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
- Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
- A Research Study of a New Medicine NNC0113-6856 in Healthy Males
- Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
- Study of Tirzepatide for Recovery and Alcohol Use Management
- Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
- Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes
- A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function
- TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
- Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
- Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
- Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)
- Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
- A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
- In-patient Study in Patients With Type 2 Diabetes Mellitus
- Combination Therapy for Alcohol Use Disorder
- Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
- Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
- Reversal to Normoglycemia by Treating Prediabetes
- GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
- Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
- Role of Exenatide in Type 1 Diabetes
- Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
- Semaglutide 2.4mg for Low Responders After Bariatric Surgery
- Effect on Weight Loss of Exenatide Versus Placebo
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)